Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: NOVOGENE CORPORATION INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-09-17 to 2022-09-20
Current total value of award: $151346.44
Description: EXERCISE OPTION YEAR 1 TO PERFORM QUALITY CONTROL OF THE DNA AND RNA THAT IS DE-IDENTIFIED.